Scientific article

Growth factors and plasticity

Published inSeminars in fetal & neonatal medicine, vol. 12, no. 4, p. 241-249
Publication date2007

Neuroprotective strategies can prevent lesions from getting worse but agents that have neurotrophic properties can also affect repair in a developing brain. Although prevention and treatment in the early stages of brain lesions are desirable, delayed cell death or improved post-lesion plasticity are the only realistic targets in many cases. Several trophic factors can limit delayed cell death in animal models of perinatal brain damage. In addition, melatonin and brain-derived neurotrophic factor have been shown to promote post-lesion plasticity following neonatal excitotoxic white-matter damage in newborn mice. Despite these promising results, additional preclinical data are required for most of the trophic factors that have been tested, although some candidate drugs, e.g. melatonin or erythropoietin, might reach clinical trials in the near future.

  • Animals
  • Animals, Newborn
  • Brain/drug effects/physiology
  • Clinical Trials as Topic
  • Erythropoietin/pharmacology
  • Humans
  • Intercellular Signaling Peptides and Proteins/pharmacology
  • Melatonin/pharmacology
  • Mice
  • Neuronal Plasticity/drug effects
  • Neuroprotective Agents/pharmacology
Citation (ISO format)
SIZONENKO, Stéphane, BEDNAREK, Nathalie, GRESSENS, Pierre. Growth factors and plasticity. In: Seminars in fetal & neonatal medicine, 2007, vol. 12, n° 4, p. 241–249. doi: 10.1016/j.siny.2007.01.007
Main files (1)
Article (Published version)
ISSN of the journal1744-165X

Technical informations

Creation12/22/2014 3:21:00 PM
First validation12/22/2014 3:21:00 PM
Update time03/14/2023 10:34:05 PM
Status update03/14/2023 10:34:05 PM
Last indexation05/02/2024 3:52:21 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack